American International Group, Inc. Krystal Biotech, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$108.01 - $179.35 $9,936 - $16,500	-92 Reduced 0.86%	10,652 $1.9 Million
Q4 2023 Feb 13, 2024	SELL	$96.0 - $128.29 $4,128 - $5,516	-43 Reduced 0.4%	10,744 $1.33 Million
Q3 2023 Nov 13, 2023	BUY	$108.51 - $130.22 $41,559 - $49,874	383 Added 3.68%	10,787 $1.25 Million
Q2 2023 Aug 04, 2023	BUY	$78.48 - $130.32 $8,475 - $14,074	108 Added 1.05%	10,404 $1.22 Million
Q1 2023 May 12, 2023	BUY	$72.39 - $84.27 $14,767 - $17,191	204 Added 2.02%	10,296 $824,000
Q4 2022 Feb 10, 2023	SELL	$63.14 - $79.9 $2,336 - $2,956	-37 Reduced 0.37%	10,092 $799,000
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $21,076 - $26,780	325 Added 3.31%	10,129 $706,000
Q2 2022 Aug 12, 2022	SELL	$48.93 - $73.47 $9,003 - $13,518	-184 Reduced 1.84%	9,804 $644,000
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $23,759 - $32,954	457 Added 4.79%	9,988 $665,000
Q4 2021 Feb 11, 2022	SELL	$39.81 - $88.24 $11,306 - $25,060	-284 Reduced 2.89%	9,531 $667,000
Q3 2021 Nov 12, 2021	SELL	$52.01 - $71.77 $12,170 - $16,794	-234 Reduced 2.33%	9,815 $512,000
Q2 2021 Aug 13, 2021	BUY	$62.14 - $81.82 $78,607 - $103,502	1,265 Added 14.4%	10,049 $683,000
Q1 2021 May 07, 2021	BUY	$59.42 - $85.46 $54,963 - $79,050	925 Added 11.77%	8,784 $677,000
Q4 2020 Feb 12, 2021	SELL	$40.64 - $61.38 $9,184 - $13,871	-226 Reduced 2.8%	7,859 $472,000
Q3 2020 Nov 04, 2020	BUY	$37.76 - $48.49 $29,264 - $37,579	775 Added 10.6%	8,085 $348,000
Q2 2020 Aug 12, 2020	BUY	$37.03 - $60.0 $40,621 - $65,820	1,097 Added 17.66%	7,310 $303,000
Q1 2020 May 04, 2020	SELL	$35.02 - $65.64 $12,607 - $23,630	-360 Reduced 5.48%	6,213 $269,000
Q4 2019 Feb 05, 2020	SELL	$33.17 - $65.23 $1,824 - $3,587	-55 Reduced 0.83%	6,573 $364,000
Q3 2019 Nov 08, 2019	BUY	$34.72 - $51.3 $36,664 - $54,172	1,056 Added 18.95%	6,628 $230,000
Q2 2019 Aug 13, 2019	BUY	$27.2 - $41.2 $151,558 - $229,566	5,572 New	5,572 $224,000

Others Institutions Holding KRYS

# of Institutions

266

Shares Held

25M

Call Options Held

270K

Put Options Held

172K

Black Rock Inc. New York, NY

3.95M
Shares

$699 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.87M
Shares

$508 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.43M
Shares

$431 Million
6.1% of portfolio
State Street Corp Boston, MA

1.33M
Shares

$236 Million
0.01% of portfolio
Redmile Group, LLC San Francisco, CA

1.02M
Shares

$181 Million
12.22% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.55B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account